Respiratory care devices serve to diagnose and treat respiratory diseases such as pneumonia, COPD, tuberculosis, and asthma. These devices improve the care of patients with chronic and acute respiratory diseases. The rise in the prevalence of respiratory diseases over the last decade is a key factor augmenting the sales growth of the anesthesia and respiratory devices market. During surgical procedures, local anesthetic devices are used to control heart rate, breathing, pain, pulse rate, blood flow, and rhythm. Anesthesia causes a loss of sensation or awareness in patients, which can include amnesia (loss of memory), unconsciousness, analgesia (pain relief or prevention), or paralysis (muscle relaxation).
Consumer demand for anesthesia and respiratory devices is increasing due to rising health awareness and the prevalence of respiratory disorders globally, which drives the global anesthesia and respiratory devices market. The rise in the number of surgical procedures worldwide is positively influencing market growth. Medical device technological advancements in the developed and emerging economies and the presence of emerging manufacturer presence will further intensify the overall market competition.
Additionally, the advent of digitalization support product manufacturers will help players gain a competitive edge in the coming years. Leading players in the global anesthesia and respiratory devices market should accelerate product innovation in order to capitalize on revenue opportunities that come with new product launches and ensure smooth revenue flow in the near future. Some of the key players of the global anesthesia and respiratory devices market include Teleflex Incorporated, Smiths Medical, Philips Healthcare, GE Healthcare, Getinge Group, Draegerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, Covidien Plc., CareFusion Corporation, B.Braun Melsungem AG, AirSep, and others.
Anesthesia devices are employed in all types of surgeries because they are designed to deliver a precise and uninterrupted supply of mixed medical gases and anesthetic vapour to a patient at a safe pressure and flow. In nations like Brazil and the United States, the number of neurological, cardiac, and other serious illnesses is rising at a rapid rate. Anesthesia devices are used during surgical procedures to control breathing, pain, blood pressure, heart rate, rhythm, and blood flow. Anesthesia can cause medical conditions such as paralysis (muscle relaxation), unconsciousness, analgesia (pain relief or prevention), and amnesia (loss of memory).
Advent of Wireless Technology and Integrated IT Solutions in Medical Sector will Bolster Growth
A low rate of new technologies being adopted by healthcare professionals may create challenges for the anesthesia and respiratory devices market growth. Another barrier to business expansion will be a lack of trained or educated health practitioners in these areas. Strict requirements for medical equipment approval would stymie growth even more. The demand for anesthetic and respiratory devices is expected to rise as technology advances. Manufacturers’ involvement in care delivery innovation through the integration of better patient monitors, novel metrics, processes, wireless devices, and integrated IT solutions exacerbates the need. These advancements enabled doctors, therapists and anesthesiologists continue providing personalized services to their patients.
Demographically, the market is widespread into the regions of North America, Europe, Latin America, Europe, and the Middle East and Africa. Each of these regions is further categorized on the basis of nations as per their contribution in the form of innovative launches and revenue. Among these, North America emerged as the largest revenue generator for the anesthesia and respiratory devices market, attributable to the presence of major players and their innovative product launches. Besides this, the presence of well-established infrastructure and better medical facilities will help this region continue dominating the market in the coming years.